Ascension's PyroCarbon foot implant:
This article was originally published in Clinica
Ascension Orthopedics has received US FDA 510(k) approval to sell its first PyroCarbon implant for use in the lower extremities. The PyroSphere device is designed for the fourth and fifth tarsometatarsal joints in people suffering from the debilitating effects of arthritis in the foot. The Austin, Texas firm noted that it has expanded its product platforms to include arthroplasty, trauma and tissue regeneration. It currently offers over 10 arthroplasty products, a complete elbow trauma set and a tissue regeneration portfolio.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.